MoneyWorks4Me

Orchasp Ltd (ORCHASP)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532271 NSE: ORCHASP IT - Software | Small Cap | Orchasp Share Price

₹1.12 0.00 (0.00%)

As on 19-Oct'26 16:59

Orchasp Ltd (ORCHASP)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532271 NSE: ORCHASP IT - Software | Small Cap | Orchasp Share Price

₹1.12 0.00 (0.00%)

As on 19-Oct'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹39 Cr.
Current Price
₹1.1
52-Week Low / High
₹1 / 4
TTM EPS
₹0
TTM Sales
₹15.6 Cr.
Book Value per Share
₹3.5
P/E Ratio
49.11
Higher than its 5-year historical median
Industry PE
21.7
Price to Book (P/B)
0.32
Lower than its 5-year historical median
Price to Sales (P/S)
2.49
Lower than its 5-year historical median
EV/EBITDA
69.95
Higher than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
0.90%
Underperforms industry median
Return on Capital Employed (ROCE)
0.84%
Underperforms industry median
Return on Assets (ROA)
0.49%
Operating Profit Margin
-13.3%
Net Profit Margin
4.95%
Gross Profit Margin
5.2%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
0.85%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
18.48%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹53 Cr.
Equity
₹69.3 Cr.
Face Value
₹2
All Time Low / High
₹0.47 / 470.60

Orchasp stock performance

Key Ratios
mw4me loader

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Orchasp Ltd a good quality company?
Orchasp Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Orchasp Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Orchasp Ltd vs industry peers?
Orchasp Ltd revenue CAGR is 21.05%, compared to the industry median CAGR of 0%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Orchasp Ltd?
Promoters hold 18.48% of the Orchasp Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Orchasp Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 2.7% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Orchasp Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation ⓘ

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
ROCE % ⓘ12.3%12.1%13.3%1.8%1%0.7%1%1.2%-8.3%0.8%-
Value Creation
Index ⓘ
-0.1-0.1-0.1-0.9-0.9-1.0-0.9-0.9-1.6-0.9-

Growth Parameters ⓘ

Sales ⓘ53.510560.451.58.237.323.513.321.121.316
Sales YoY Gr.-95.7%-42.3%-14.8%-84.1%355.9%-37.1%-43.5%59.1%0.9%-
Adj EPS ⓘ0.30.50.40.10-0-0.30-0.1-0.10
YoY Gr.-46.9%-21.3%-73%-70%-233.3%NANA-600%NA-
BVPS (₹) ⓘ2.22.99.79.810.210.28.97.23.53.53.5
Adj Net
Profit ⓘ
2.33.83.610.3-0.4-30.2-1.5-1.61
Cash Flow from Ops. ⓘ-2.2-2.5-2.11.7-4.4-120.40.3-15.6-4.2-
Debt/CF from Ops. ⓘ-2.5-2.3-2.11.5-1.7-1.74948.5-1-1.7-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘ-9.7%21.1%-3.2%0.9%
Adj EPS ⓘ-181.4%-210.8%NANA
BVPSⓘ5.2%-19.1%-26.7%0.3%
Share Price 2.2% -16.4% -25.1% -68.1%

Key Financial Parameters ⓘ

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
Return on
Equity % ⓘ
15.519.161.10.3-0.4-30.2-1.4-1.40.6
Op. Profit
Mgn % ⓘ
8.43.78.53.70.60.3-15.35.69.4-13.3-24.9
Net Profit
Mgn % ⓘ
4.33.7623.4-1.1-12.91.5-7.2-7.74.4
Debt to
Equity ⓘ
0.40.20.100.10.20.20.10.10.1-
Working Cap
Days ⓘ
2291352463572,5766751,4262,9872,1032,5402,724
Cash Conv.
Cycle ⓘ
155992082921,9125181,0071,5631,0211,298877

Valuation of Orchasp - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Financials

PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Sales53.49104.6760.4482.598.1837.2923.4613.2521.0821.26
Operating Expenses > ⓘ + 48.99100.8055.3280.088.2237.2027.0512.5131.9624.08
Manufacturing Costs0.0434.412.821.760.545.790.690.040.040.05
Material Costs0.010.05030.3200.340.4900.060.04
Employee Cost 37.4858.3848.9545.156.2329.6424.5910.7317.5522.13
Other Costs > ⓘ 11.467.963.552.841.461.431.291.7314.311.86
Operating Profit > ⓘ 4.493.875.122.52-0.040.09-3.600.74-10.88-2.83
Operating Profit Margin (%) 8.4%3.7%8.5%3.0%-0.5%0.2%-15.3%5.6%-51.6%-13.3%
Other Income > ⓘ + 00.013.690.201.140.774.920.800.543.94
Exceptional Items > ⓘ 0000000000
Interest > ⓘ 00.011.260.660.650.660.790.680.150.02
Depreciation > ⓘ 2.100.770.150.140.100.060.060.040.030.04
Profit Before Tax > ⓘ 2.393.117.401.920.340.150.480.82-10.511.06
Tax > ⓘ 0.07-0.701.200.240.130.090.130.140.010.01
Profit After Tax 2.323.816.211.680.210.060.350.68-10.521.05
PAT Margin (%) 4.3%3.6%10.3%2.0%2.6%0.2%1.5%5.1%-49.9%5.0%
Adjusted EPS (₹)0.30.50.60.20.00.00.00.1-0.30.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26

Equity and Liabilities

Shareholders Fund + 16.1323.5896.3498.02100.59100.65101108.08112.16121.81
Share Capital ⓘ 14.4916.1119.7919.7919.7919.7922.5929.9763.9169.29
Reserves ⓘ 1.647.4876.5578.2380.8080.8678.4178.1148.2552.52
Debt +2.602.554.552.467.5820.6020.9715.1515.667.33
Long Term Debt0000000000
Short Term Debt2.602.554.552.467.5820.6020.9715.1515.667.33
Minority Interest0000000000
Trade Payables10.542.522.698.6712.1113.7040.7342.0859.8188.20
Others Liabilities ⓘ 16.049.8212.2114.709.2810.3712.2713.8413.6914.66
Total Liabilities ⓘ 45.3138.48115.80123.85129.56145.32174.98179.15201.32231.99

Fixed Assets

Net Fixed Assets ⓘ +2.661.960.380.240.170.110.060.090.130.11
Gross Block44.2444.3242.0442.0442.0742.0842.0839.8739.9339.95
Accumulated Depreciation41.5842.3541.6641.8041.9141.9742.0339.7739.8039.84
CWIP ⓘ 0000000000
Investments ⓘ 0.01068.2568.2568.2568.2668.2668.2668.2668.26
Inventories0000000000
Trade Receivables39.9031.4543.3352.2158.2273.94103.58107.56129.73160.26
Cash Equivalents 0.131.470.830.070.120.070.200.460.320.31
Others Assets ⓘ 2.613.583.013.072.792.942.882.782.893.06
Total Assets ⓘ 45.3138.48115.80123.85129.56145.32174.98179.15201.32231.99
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Cash Flow From Operating Activity ⓘ + -2.24-2.47-2.121.68-3.59-12.020.430.31-15.58-4.20
PBT ⓘ 2.393.117.401.920.340.150.480.82-10.511.06
Adjustment ⓘ 2.100.771.400.790.750.610.730.59-0.37-3.90
Changes in Working Capital ⓘ -6.16-6.43-10.93-0.81-4.6-12.75-0.66-0.97-4.7-1.36
Tax Paid ⓘ -0.570.080-0.23-0.09-0.02-0.12-0.1300
Cash Flow From Investing Activity ⓘ + -0.07-0.06-63.450.28-3.18-0.400.090.050.483.92
Capex -0.07-0.071.44-0-0.03-0-0.01-0.07-0.06-0.02
Net Investments 00.01-68.260000000
Others ⓘ 003.370.28-3.15-0.400.100.120.543.94
Cash Flow From Financing Activity ⓘ + 2.283.8764.93-2.746.8312.37-0.40-0.0914.960.27
Net Proceeds from Shares ⓘ 03.933.6800006.4014.608.60
Net Proceeds from Borrowing ⓘ 0000000000
Interest Paid ⓘ 00-1.25-0.65-0.65-0.65-0.78-0.67-0.150
Dividend Paid ⓘ 0000000000
Others ⓘ 2.28-0.0562.50-2.097.4813.020.38-5.830.51-8.33
Net Cash Flow ⓘ -0.021.34-0.64-0.780.05-0.050.120.27-0.14-0.01
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Ratios
ROE (%)15.5219.1910.351.730.210.060.350.65-9.560.9
ROCE (%)12.312.1413.282.560.950.71.041.23-8.260.84
Asset Turnover Ratio1.432.50.780.690.060.270.150.070.110.1
PAT to CFO Conversion(x)-0.97-0.65-0.341-17.1-200.331.230.46N/A-4
Working Capital Days
Receivable Days215.40124.40225.80211.102,462.80646.801,381.202,909.202,0542,489.70
Inventory Days0000000000
Payable Days00068.40000000

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Orchasp Ltd FAQs

The current trading price of Orchasp on 19-Oct-2026 16:59 is ₹1.12.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 18-Oct-2026 the market cap of Orchasp stood at ₹38.80 Cr

The latest P/E ratio of Orchasp as of 18-Oct-2026 is 49.18.

The latest P/B ratio of Orchasp as of 18-Oct-2026 is 0.32.

The 52-week high of Orchasp is ₹3.89 and the 52-week low is ₹1.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Orchasp is ₹15.59 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Orchasp Ltd is a below average quality company.

The key valuation ratios of Orchasp Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Orchasp Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Orchasp Ltd

Cybermate Infotek  (CIL) founded in May 1994 is a software solutions and IT services company. The company was founded at Hyderabad, India and is a 100% Export Oriented Unit (EOU). CIL is a offshore software development company executing projects on web & web related technologies (Both Microsoft & Java).

A team of qualified & experienced professionals have promoted the company with a humble beginning of its services in the Indian markets and gradually moved into the European markets in 1997 and subsequently into the US.

The company made an Initial Public Offer (IPO) during February 1998, which received an immense response and was oversubscribed 27 times. Currently, the stocks are very actively traded on the Bombay Stock Exchange.

CIL has been building and deploying end-to-end IT solutions for a wide range of companies globally. Cybermate Infotek Limited offers world-class offshore outsourcing and consulting services specializing in IT-enabled services, back office outsourcing services and business process outsourcing solutions from India guaranteed to cut costs and improve quality.

Products and services offered by the company:

Following are the products that Cybermate today sells in American, European and Indian Markets.

  • CinfotekCARDS: A complete print order management solution for the print industry.
  • eTearsheetâ„¢: Digital distribution of proof of publication of advertisements & tearsheet management.
  • EZDMSâ„¢: Simplified low cost Document Management System using Adobe PDF.
  • Fleetplusâ„¢: Realtime vehicle monitoring & fleet management in companies with large fleets.
  • TopAccessâ„¢: Comprehensive suite of solutions for CounterTop manufacturing & retail.
  • CyberCare: A full functionality Hospital Management Solution for India.
  • RCMS: A comprehensive retail & wholesale distribution management software package, uniquely designed to suite a single outlet or a multiple / chain of retail stores viz., Super markets and the likes.
  • Medrep: A product for pharmaceutical companies to manage & communicate the effectiveness of the medical representatives in the field.

Services:

  • Web applications for e-Commerce.
  • Enterprise Middleware Components.
  • Wireless Applications.
  • Solutions for Industry Verticals.
  • Professional Services.
You have 3 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now